Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,931 articles, preprints and more)

Ciro Celsa

Visit ORCID profile

102

Publications
in ORCID

Publications
in Europe PMC

Free full text articles
in Europe PMC

329

Open citations
in Europe PMC

Want your own profile? Link your articles to your ORCID in 2 simple steps.

Publications listed in Europe PMC (28)

Sort by:

Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G, Celsa C, Calvaruso V, Petta S, Cacciola I, Cannavò MR, Madonia S, Rossi M, Magro B, Rini F, Distefano M, Larocca L, Prestileo T, Malizia G, Bertino G, Benanti F, Licata A, Scalisi I, Mazzola G, [...] Rete Sicilia Selezione Terapia – HCV (RESIST-HCV) and Italian Liver Cancer (ITA.LI.CA.) Group
J Hepatol, 71(2):265-273, 06 Apr 2019
Cited by: 76 articles | PMID: 30959157
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Sapena V, Enea M, Torres F, Celsa C, Rios J, Rizzo GEM, Nahon P, Mariño Z, Tateishi R, Minami T, Sangiovanni A, Forns X, Toyoda H, Brillanti S, Conti F, Degasperi E, Yu ML, Tsai PC, Tsai PC, [...] Reig M
Gut, 71(3):593-604, 19 Mar 2021
Cited by: 39 articles | PMID: 33741640
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19.
Villa E, Critelli R, Lasagni S, Melegari A, Curatolo A, Celsa C, Romagnoli D, Melegari G, Pivetti A, Di Marco L, Casari F, Arioli D, Turrini F, Zuccaro V, Cassaniti I, Riefolo M, de Santis E, Bernabucci V, Bianchini M, [...] d'Errico A
Blood Adv, 5(3):662-673, 01 Feb 2021
Cited by: 31 articles | PMID: 33560382 | PMCID: PMC7876870
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives.
Pennisi G, Celsa C, Giammanco A, Spatola F, Petta S
Int J Mol Sci, 20(22):E5613, 09 Nov 2019
Cited by: 27 articles | PMID: 31717576 | PMCID: PMC6887792
Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?
Tacelli M, Celsa C, Magro B, Giannetti A, Pennisi G, Spatola F, Petta S
Pharmaceuticals (Basel), 11(4):E121, 08 Nov 2018
Cited by: 23 articles | PMID: 30413050 | PMCID: PMC6316860
Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Risk Factors for Rate of Relapse and Effects of Steroid Maintenance Therapy in Patients With Autoimmune Pancreatitis: Systematic Review and Meta-analysis.
Tacelli M, Celsa C, Magro B, Barresi L, Guastella S, Capurso G, Frulloni L, Cabibbo G, Cammà C
Clin Gastroenterol Hepatol, 17(6):1061-1072.e8, 10 Oct 2018
Cited by: 18 articles | PMID: 30312787
Review
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use.
Magro B, Zuccaro V, Novelli L, Zileri L, Celsa C, Raimondi F, Gori M, Cammà G, Battaglia S, Genova VG, Paris L, Tacelli M, Mancarella FA, Enea M, Attanasio M, Senni M, Di Marco F, Lorini LF, Fagiuoli S, [...] Gasbarrini A
PLoS One, 16(1):e0245281, 14 Jan 2021
Cited by: 16 articles | PMID: 33444411 | PMCID: PMC7808616
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials.
Cabibbo G, Cucchetti A, Cammà C, Casadei-Gardini A, Celsa C, Emanuele Maria Rizzo G, Johnson P, Ercolani G
Future Oncol, 15(29):3411-3422, 07 Oct 2019
Cited by: 13 articles | PMID: 31588789
Review
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model.
Vizzutti F, Celsa C, Calvaruso V, Enea M, Battaglia S, Turco L, Senzolo M, Nardelli S, Miraglia R, Roccarina D, Campani C, Saltini D, Caporali C, Indulti F, Gitto S, Zanetto A, Di Maria G, Bianchini M, Pecchini M, [...] Schepis F
Hepatology, 77(2):476-488, 17 Aug 2022
Cited by: 12 articles | PMID: 35921493
Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma.
Cabibbo G, Celsa C, Enea M, Battaglia S, Rizzo GEM, Busacca A, Matranga D, Attanasio M, Reig M, Craxì A, Cammà C
Cancers (Basel), 13(1):E90, 30 Dec 2020
Cited by: 11 articles | PMID: 33396833 | PMCID: PMC7796103
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives.
Pennisi G, Celsa C, Spatola F, Dallio M, Federico A, Petta S
Int J Environ Res Public Health, 16(22):E4334, 07 Nov 2019
Cited by: 11 articles | PMID: 31703268 | PMCID: PMC6888162
Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
Celsa C, Cabibbo G, Fulgenzi CAM, Scheiner B, D'Alessio A, Manfredi GF, Nishida N, Ang C, Marron TU, Saeed A, Wietharn B, Pinter M, Cheon J, Huang YH, Lee PC, Phen S, Gampa A, Pillai A, Vivaldi C, [...] Pinato DJ
J Hepatol, 80(3):431-442, 15 Nov 2023
Cited by: 9 articles | PMID: 37972660
Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis.
Cabibbo G, Celsa C, Enea M, Battaglia S, Rizzo GEM, Grimaudo S, Matranga D, Attanasio M, Bruzzi P, Craxì A, Cammà C
Cancers (Basel), 12(8):E2132, 31 Jul 2020
Cited by: 8 articles | PMID: 32752060 | PMCID: PMC7464739
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?
Cabibbo G, Celsa C, Cammà C, Craxì A
Liver Int, 38(12):2108-2116, 21 Jul 2018
Cited by: 8 articles | PMID: 29935096
Review
Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization?
Celsa C, Cabibbo G, Enea M, Battaglia S, Rizzo GEM, Busacca A, Giuffrida P, Stornello C, Brancatelli G, Cannella R, Gruttadauria S, Cammà C
Liver Int, 41(5):1105-1116, 01 Mar 2021
Cited by: 7 articles | PMID: 33587814
Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCC.
Cannella R, Cammà C, Matteini F, Celsa C, Giuffrida P, Enea M, Comelli A, Stefano A, Cammà C, Midiri M, Lagalla R, Brancatelli G, Vernuccio F
Diagnostics (Basel), 12(6):1308, 24 May 2022
Cited by: 6 articles | PMID: 35741118 | PMCID: PMC9221802
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma Patients.
Pelizzaro F, Vitale A, Sartori A, Vieno A, Penzo B, Russo FP, Frigo AC, Giannini EG, Piccinnu M, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Sacco R, Celsa C, Marra F, Mega A, Guarino M, Gasbarrini A, [...] On Behalf Of Ita Li Ca Study Group
Cancers (Basel), 13(4):897, 20 Feb 2021
Cited by: 5 articles | PMID: 33672751 | PMCID: PMC7924561
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
No graph available until there is a citation in more than one year
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs.
Carr BI, Guerra V, Donghia R, Farinati F, Giannini EG, Muratori L, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Sacco R, Celsa C, Campani C, Mega A, Guarino M, Gasbarrini A, Gasbarrini A, Svegliati-Baroni G, Foschi FG, [...] Trevisani F
Cancers (Basel), 13(4):592, 03 Feb 2021
Cited by: 4 articles | PMID: 33546234 | PMCID: PMC7913341
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
No graph available until there is a citation in more than one year
The Relevance of Noninvasive Tools To Assess Fibrosis in Non-Alcoholic Fatty Liver Disease.
Pennisi G, Celsa C, Giammanco A, Spatola F, Petta S
Curr Pharm Des, 26(32):3928-3938, 01 Jan 2020
Cited by: 2 articles | PMID: 32436818
No graph available until there is a citation in more than one year
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study.
Pinato DJ, D'Alessio A, Fulgenzi CAM, Schlaak AE, Celsa C, Killmer S, Blanco JM, Ward C, Stikas CV, Openshaw MR, Acuti N, Nteliopoulos G, Balcells C, Keun HC, Goldin RD, Ross PJ, Cortellini A, Thomas R, Young AM, [...] Sharma R
Clin Cancer Res, 30(11):2433-2443, 01 Jun 2024
Cited by: 1 article | PMID: 38578610 | PMCID: PMC11145164
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
No graph available until there is a citation in more than one year
Evaluating the risk-benefit ratio of immunotherapy according to liver-functional reserve in advanced HCC: the dark side of the moon.
Cabibbo G, Celsa C, Alimenti E, Iavarone M
Hepatology, 77(4):1074-1077, 03 Jan 2023
Cited by: 1 article | PMID: 36626617
No graph available until there is a citation in more than one year
The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints.
Giuffrida P, Celsa C, Antonucci M, Peri M, Grassini MV, Rancatore G, Giacchetto CM, Cannella R, Incorvaia L, Corsini LR, Morana P, La Mantia C, Badalamenti G, Brancatelli G, Cammà C, Cabibbo G
Biomedicines, 10(11):2827, 06 Nov 2022
Cited by: 1 article | PMID: 36359347 | PMCID: PMC9687474
Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
No graph available until there is a citation in more than one year
What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis.
Celsa C, Rizzo GEM, Di Maria G, Enea M, Vaccaro M, Rancatore G, Graceffa P, Falco G, Petta S, Cabibbo G, Calvaruso V, Craxì A, Cammà C, Di Marco V
Liver Int, 44(11):2890-2903, 29 Aug 2024
Cited by: 0 articles | PMID: 39206573
No graph available until there is a citation in more than one year
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.
Celsa C, Cabibbo G, Fulgenzi CAM, Battaglia S, Enea M, Scheiner B, D'Alessio A, Manfredi GF, Stefanini B, Nishida N, Galle PR, Schulze K, Wege H, Ciccia R, Hsu WF, Vivaldi C, Wietharn B, Lin RP, Pirozzi A, [...] Pinato DJ
Hepatology, 19 Jul 2024
Cited by: 0 articles | PMID: 39028886
No graph available until there is a citation in more than one year
Reply.
Vizzutti F, Celsa C, Battaglia S, Miraglia R, Enea M, Marra F, Caporali C, Cammà C, Schepis F
Hepatology, 77(4):E76-E77, 12 Oct 2022
Cited by: 0 articles | PMID: 36177688
No graph available until there is a citation in more than one year
Reply.
Vizzutti F, Celsa C, Battaglia S, Miraglia R, Enea M, Marra F, Colecchia A, Cammà C, Schepis F
Hepatology, 77(3):E57-E58, 17 Feb 2023
Cited by: 0 articles | PMID: 36098577
No graph available until there is a citation in more than one year
Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals.
Vernuccio F, Cannella R, Cabibbo G, Greco S, Celsa C, Matteini F, Giuffrida P, Midiri M, Di Marco V, Cammà C, Brancatelli G
Diagnostics (Basel), 12(5):1187, 10 May 2022
Cited by: 0 articles | PMID: 35626341 | PMCID: PMC9140370
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
No graph available until there is a citation in more than one year
Editorial: proton pump inhibitor use in cirrhosis-a piece of the puzzle.
Celsa C, Cammà C
Aliment Pharmacol Ther, 53(5):663-664, 01 Mar 2021
Cited by: 0 articles | PMID: 33566403

Show less

Search life-sciences literature (45,104,931 articles, preprints and more)

Ciro Celsa

Publications listed in Europe PMC (28)

Partnerships & funding